Humans aren’t the only ones who suffer from seasonal allergies. When the weather warms up in the spring, many dog owners ...

The only JAK inhibitor approved in the U.S. for the control of pruritus associated with allergic dermatitis in dogs six months of age and older “Merck Animal Health is proud to introduce NUMELVI, our ...

On Thursday, the FDA approved Elanco Animal Health Incorporated’s (NYSE:ELAN) Zenrelia, a once-daily oral JAK inhibitor for the control of pruritus (itching) associated with allergic dermatitis and ...

Sept 19 (Reuters) - The U.S. Food and Drug Administration has approved Elanco Animal Health's (ELAN.N), opens new tab skin disease treatment for dogs, the health regulator's website showed on Thursday ...

SAN FRANCISCO, July 29, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced ...

Using new gene mapping methods, researchers have found connections between atopic dermatitis (eczema) in dogs and several regions of the genome. Some of the genes identified coincide with genes linked ...

For more information about the first and only second-generation JAK inhibitor for the treatment of allergic dermatitis in dogs from six months of age, visit numelvi.com. References: Hill PB, Lo A, ...

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the U.S. Food and Drug ...